If you’re living with Primary Biliary Cholangitis, learn about our study of a novel combination therapy
Primary Biliary Cholangitis may be rare. But we’re working together.
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Christopher Bowlus, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Davis
- Christopher Bowlus, MD
Professor, Gastroenterology and Hepatology, School of Medicine. Authored (or co-authored) 196 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Intercept Pharmaceuticals
- Links
- Sign up for this study
- ID
- NCT05239468
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 60 study participants
- Last Updated